Journal Article Summary
The article investigates the cardiovascular safety of 5α-reductase inhibitors, commonly prescribed for benign prostatic hyperplasia (BPH), particularly in men with type 2 diabetes. This topic is significant because individuals with type 2 diabetes are already at a heightened risk for cardiovascular diseases, and previous studies have suggested that 5α-reductase inhibitors may increase the risk of developing diabetes. Understanding the long-term cardiovascular effects of these medications is crucial for ensuring patient safety and guiding treatment decisions for those with both BPH and diabetes.
The researchers conducted a retrospective analysis using data from two large UK cohorts, the Scottish Diabetes Research Network and IQVIA Medical Research Data. They included male patients aged 40 and older who had been prescribed either 5α-reductase inhibitors or tamsulosin, a common alternative treatment for BPH, between 2006 and 2021. The study found that patients taking 5α-reductase inhibitors had a higher risk of major adverse cardiovascular events (MACE), particularly myocardial infarction (MI), compared to those using tamsulosin. Specifically, the hazard ratios indicated a significant increase in the risk of MACE and MI among users of 5α-reductase inhibitors in both datasets analyzed.
However, the study has limitations, including potential biases due to the retrospective nature of the data and differences in how diagnoses were recorded in the two datasets. Additionally, the study did not measure medication adherence, which could affect the results. Patients should discuss these findings with their healthcare professionals, especially if they are prescribed 5α-reductase inhibitors, to ensure they are monitored for cardiovascular health and to consider alternative treatments if necessary. Understanding the risks associated with these medications is essential for making informed decisions about their use in managing BPH alongside diabetes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Tu Haolan, Ju Chengsheng, McGurnaghan Stuart J, Blackbourn Luke A K, Scottish Diabetes Research Network Epidemiology Group HanlonPeterLindsayRobertMcAllisterDavidPetrieJohnSattarNaveedKennonBrianPhilipSamCunninghamScottPearsonEwanWangHuanBerthonWilliamBlackbournLukeColhounHelenMcGurnaghanStuartMcKeiguePaulWildSarah, Hanlon Peter, Lindsay Robert, McAllister David, et al.. Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis. European Heart Journal. Cardiovascular Pharmacotherapy 2026. DOI: 10.1093/ehjcvp/pvag003. PMID: 41544653. PMCID: PMC12946974.
Featured Pill Pals Product
Tamsulosin 0.4 mg Capsules --- Generic For Flomax --- Aurobindo
Tamsulosin 0.4 mg Capsules — Generic For Flomax — Aurobindo is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
